Yogesh D. Sadhale, PhD
Associate Director, Pharmaceutical Development
Dr. Sadhale manages all aspects of personnel and operations related to formulating and manufacturing a client’s pharmaceutical materials for Phase I, II and III clinical trials. In his position, Dr. Sadhale is responsible for scale up and validation of clinical trial materials, and manufacturing and packaging clinical trial batches under Current Good Manufacturing Practices (cGMP) guidelines. In addition, Dr. Sadhale provides planning and budgeting for pharmaceutical development operations, and hires, trains and manages pharmaceutical development staff. With 20 years of experience in the pharmaceutical industry, Dr. Sadhale previously worked at Patheon Manufacturing Services, where he managed pharmaceutics and process development. He holds a doctorate in pharmaceutical sciences from the Medical University of South Carolina.
Manager, Pharmaceutical Development
Mr. Stox directs a team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials, and then scale up and support the validation and commercialization of those products. He is focused on day-to-day “right first time” initiatives and time management of schedules and staff. Mr. Stox also provides planning and budgeting for operations within the pharmaceutical development department as well as hires, trains and manages the pharmaceutical development staff. With 25 years of industry experience in oral solid dose manufacturing, Mr. Stox previously worked as a quality control production supervisor at Burroughs Wellcome, in quality control management at DSM Dyneema, and as Senior Supervisor and Project Manager for Solid Oral Dosage forms and department SME at DSM Pharmaceuticals. Mr. Stox holds a Bachelor of Science in Chemistry from East Carolina University.
Director, Analytical Services
Ms. Garrett manages team group leaders and lab supervisors responsible for conducting analytical laboratory services for clients. Among other duties, she reviews and approves specifications, methodology validation protocols and reports, stability testing, certificates of analysis and release reports for raw and in-process materials, active pharmaceutical ingredients, and finished products; reviews and approves regulatory submissions; and trains lab personnel on preparing documents for regulatory and cGMP review. Ms. Garrett joined Metrics Contract Services in 1999. She earned her bachelor’s of science degree in chemistry from East Carolina University.
Jerry (Junior) Mizell
Director, Analytical Services
Mr. Mizell manages a team of group leaders responsible for conducting analytical laboratory services for clients. Among other duties, he reviews and approves regulatory submissions; reviews specifications, methodology validation, stability testing, analytical investigations and release reports for raw and in-process materials, active pharmaceutical ingredients and finished products; and reviews and approves method validation protocols and reports. A member of the American Chemical Society and AAPS, Mr. Mizell joined Metrics Contract Services in 1995 after working at Burroughs Wellcome, now part of GSK. He holds a bachelor’s of science degree in chemistry from East Carolina University.